Invitrogen Licenses IMBcom's Non-Coding RNAs | GenomeWeb
NEW YORK (GenomeWeb News) – Invitrogen announced today that it has licensed exclusive rights from Australian company IMBcom to commercialize new non-coding RNA molecules as they are developed.
Invitrogen said the agreement will expand its RNA product portfolio, and its NCode microRNA microarray product line in particular.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.